ARTICLE | Clinical News
HyperAcute Melanoma: Phase II data
June 13, 2011 7:00 AM UTC
An open-label, U.S. Phase II trial in 16 patients with stage IV melanoma showed that HyperAcute Melanoma plus PEG-Intron peginterferon alfa-2b produced 2 complete responses and 1 case of stable disea...